Profound misregulation of muscle-specific gene expression in facioscapulohumeral muscular dystrophy
UMass Chan Affiliations
Howard Hughes Medical Institute, Program in Molecular MedicineDocument Type
Journal ArticlePublication Date
1999-10-27Keywords
Base SequenceDNA Primers
DNA, Complementary
Gene Expression Regulation
Humans
Molecular Sequence Data
Muscle Proteins
Muscular Dystrophy, Facioscapulohumeral
Subtraction Technique
Life Sciences
Medicine and Health Sciences
Metadata
Show full item recordAbstract
Facioscapulohumeral muscular dystrophy (FSHD) is a neuromuscular disorder characterized by an insidious onset and progressive course. The disease has a frequency of about 1 in 20,000 and is transmitted in an autosomal dominant fashion with almost complete penetrance. Deletion of an integral number of tandemly arrayed 3.3-kb repeat units (D4Z4) on chromosome 4q35 is associated with FSHD but otherwise the molecular basis of the disease and its pathophysiology remain obscure. Comparison of mRNA populations between appropriate cell types can facilitate identification of genes relevant to a particular biological or pathological process. In this report, we have compared mRNA populations of FSHD and normal muscle. Unexpectedly, the dystrophic muscle displayed profound alterations in gene expression characterized by severe underexpression or overexpression of specific mRNAs. Intriguingly, many of the deregulated mRNAs are muscle specific. Our results suggest that a global misregulation of gene expression is the underlying basis for FSHD, distinguishing it from other forms of muscular dystrophy. The experimental approach used here is applicable to any genetic disorder whose pathogenic mechanism is incompletely understood.Source
Proc Natl Acad Sci U S A. 1999 Oct 26;96(22):12650-4.